Xtant Medical Holdings, Inc.
XTNT
$0.60
$0.011.83%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 133.08M | 127.77M | 122.30M | 117.27M | 113.86M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 133.08M | 127.77M | 122.30M | 117.27M | 113.86M |
| Cost of Revenue | 50.54M | 50.91M | 51.14M | 49.05M | 44.53M |
| Gross Profit | 82.54M | 76.86M | 71.16M | 68.22M | 69.33M |
| SG&A Expenses | 74.03M | 74.60M | 76.40M | 77.90M | 80.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 126.74M | 127.74M | 129.84M | 129.34M | 127.86M |
| Operating Income | 6.35M | 28.00K | -7.54M | -12.08M | -14.00M |
| Income Before Tax | 2.26M | -4.27M | -11.90M | -16.26M | -16.85M |
| Income Tax Expenses | 508.00K | 313.00K | 94.00K | 187.00K | 743.00K |
| Earnings from Continuing Operations | 1.75 | -4.58 | -11.99 | -16.45 | -17.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.75M | -4.58M | -11.99M | -16.45M | -17.59M |
| EBIT | 6.35M | 28.00K | -7.54M | -12.08M | -14.00M |
| EBITDA | 10.90M | 4.49M | -3.25M | -7.85M | -9.91M |
| EPS Basic | 0.02 | -0.03 | -0.09 | -0.12 | -0.13 |
| Normalized Basic EPS | 0.01 | -0.02 | -0.05 | -0.07 | -0.08 |
| EPS Diluted | 0.01 | -0.04 | -0.09 | -0.12 | -0.14 |
| Normalized Diluted EPS | 0.01 | -0.02 | -0.05 | -0.07 | -0.08 |
| Average Basic Shares Outstanding | 576.34M | 571.73M | 562.69M | 553.82M | 525.59M |
| Average Diluted Shares Outstanding | 600.54M | 585.26M | 566.96M | 553.82M | 525.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |